LEIGHANDRA BARBER: Open Payments
NPI 1376921916 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,769 in 80 payments from 14 companies in 2025. Trend: 2023 $1,236 · 2024 $1,300 · 2025 $1,769
Food & beverage: $1,706Education: $63
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 26 | $550 |
| Regeneron Healthcare Solutions, Inc. | 21 | $478 |
| GlaxoSmithKline, LLC. | 11 | $164 |
| CSL Behring | 6 | $158 |
| LEO Pharma Inc. | 4 | $106 |
| SANOFI-AVENTIS U.S. LLC | 1 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Amgen Inc. | 2 | $43 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $37 |
| Blueprint Medicines Corporation | 1 | $30 |
Products named: DUPIXENT, Hizentra, NUCALA, ADBRY, TRELEGY ELLIPTA, TEZSPIRE, NEFFY, AYVAKIT.
Industry payments across KY — which companies pay providers there.
